Dr Diana Tan is a Research Fellow at the Monash Health Translational Precinct, working within the Cell-Based and Regenerative Therapies for Inflammatory Bowel Disease Group at the Centre for Inflammatory Diseases (CID), Monash University.

Diana holds a PhD in Immunology and a Bachelor of Science in Biotechnology. She completed her doctoral studies under the supervision of Professors Stephen Holdsworth and Richard Kitching, internationally recognised leaders in autoimmune kidney disease research.

After a career break to raise her young family, Diana returned to research as an early career investigator, bringing a renewed focus and passion to the study of immune regulation. Her expertise lies in regulatory T cells (Tregs) and their role in maintaining immune tolerance. Her early work using an experimental model of ANCA-associated vasculitis (AAV) has contributed to our understanding of Treg biology in autoimmune disease.

Diana's current research explores the intersection between gut inflammation, the microbiome, and immune regulation, with the goal of developing innovative, cell-based therapies for inflammatory bowel disease (IBD). She is particularly interested in translating preclinical discoveries into meaningful therapeutic strategies.